Lisdexamfetamine, sold under the brand name Vyvanse among others, is a medication that is a derivative of amphetamine. It is mainly used to treat attention deficit hyperactivity disorder (ADHD) in people over the age of five as well as moderate-to-severe binge eating disorder in adults. Reference standards of Lisdexamfetamine API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Lisdexamfetamine
Catalogue No.:PA 12 1640000
CAS :
Molecular Formula : C15H25N3O
Molecular Weight : 263.39
(R)-2,6-Diamino-N-((S)-1-phenylpropan-2-yl)hexanamide
Catalogue No.:PA 12 1641000
Lisdexamfetamine Tetramino Analog
Catalogue No.:PA 12 1641002
Molecular Formula : C27H49N7O3
Molecular Weight : 519.74
Lisdexamfetamine Carbamate Impurity
Catalogue No.:PA 12 1641001
Molecular Formula : C14H21NO2
Molecular Weight : 235.33
Bis(tert-Butoxycarbonyl) Lisdexamphetamine
Catalogue No.:PA 12 1641003
Molecular Formula : C25H41N3O5
Molecular Weight : 463.62
tert-Butyl ((S)-6-amino-1-oxo-1-(((S)-1-phenylpropan-2-yl)amino)hexan-2-yl)carbamate
Catalogue No.:PA 12 1641004
Molecular Formula : C20H33N3O3
Molecular Weight : 363.5
rel-(2R)-2,6-Diamino-N-[(1R)-1-methyl-2-phenylethyl]hexanamide
Catalogue No.:PA 12 1641005
(S)-2,6-Diamino-N-((S)-1-phenylethyl)hexanamide
Catalogue No.:PA 12 1641006
Molecular Formula : C14H23N3O
Molecular Weight : 249.36
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
